Menopause

  • Janet P. Realini

Abstract

The natural history of menopause (the cessation of menses) and the climacteric (the period of transition from reproductive to postreproductive status) involves many changes and challenges. For many women, this period in life is associated with symptoms and problems, as well as joys and benefits.

Keywords

Endometrial Cancer Endometrial Carcinoma Endometrial Hyperplasia Medroxyprogesterone Acetate Systemic Mastocytosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hammond CB. Menopause and hormone replacement therapy: an overview. Obstet Gynecol 1996;87:2S–15S.CrossRefGoogle Scholar
  2. 2.
    Thorneycroft IH. Practical aspects of hormone replacement therapy. Prog Cardiovasc Dis 1995;38:243–55.PubMedCrossRefGoogle Scholar
  3. 3.
    Lemcke DP, Marshall LA, Pattison J. Menopause and hormone replacement therapy. In: Lemcke DP, Pattison J, Marshall LA, Cowley DS, editors. Primary care of women. Norwalk, CT: Lange, 1995:161–72.Google Scholar
  4. 4.
    Burger HG, Dudley EC, Hopper JL, et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 1995;80: 3537–45.PubMedCrossRefGoogle Scholar
  5. 5.
    Kronenberg F. Hot flashes. In: Lobo RA, editor. Treatment of the postmenopausal woman: basic and clinical aspects. New York: Raven, 1994:97–117.Google Scholar
  6. 6.
    American College of Obstetricians and Gynecologists. Hormone replacement therapy. Washington, DC: ACOG, 1992. Technical Bulletin No. 166.Google Scholar
  7. 7.
    Sherwin BB. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 1996;87:20S-6S.CrossRefGoogle Scholar
  8. 8.
    Barrett-Conner E, Kritz-Silverstein K. Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269:2637–41.CrossRefGoogle Scholar
  9. 9.
    Eaker ED, Chesebro JH, Sacks FM, et al. American Heart Association medical/scientific statement special report: cardiovascular disease in women. Circulation 1993;88: 1999–2009.PubMedCrossRefGoogle Scholar
  10. 10.
    Walters M, Realini JP. Diagnosis and management of urinary incontinence in women: a primary care approach. J Am Board Fam Pract 1992;5:289–304.PubMedGoogle Scholar
  11. 11.
    Guide to clinical preventive services. 2nd ed. Report of the U.S. Preventive Services Task Force. Baltimore: Williams & Wilkins, 1996:xvi-xvii.Google Scholar
  12. 12.
    Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016–37.PubMedCrossRefGoogle Scholar
  13. 13.
    Postmenopausal hormone prophylaxis. In: Guide to clinical preventive services. 2nd ed. Report of the U.S. Preventive Services Task Force. Baltimore: Williams & Wilkins, 1996: 829–43.Google Scholar
  14. 14.
    Lindsay R. The menopause and osteoporosis. Obstet Gynecol 1996;87:16S-19S.CrossRefGoogle Scholar
  15. 15.
    Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199–208.CrossRefGoogle Scholar
  16. 16.
    Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. JAMA 1996;275:370–5.CrossRefGoogle Scholar
  17. 17.
    Cerin A, Jeldaas K, Moeller B. Adverse endometrial effects of long-cycle estrogen and progestogen replacement therapy [letter]. N Engl J Med 1996;334:668–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Stanford JL, Weiss NS, Voigt LF, et al. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995; 274:137–42.PubMedCrossRefGoogle Scholar
  19. 19.
    Colditz G A, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589–93.PubMedCrossRefGoogle Scholar
  20. 20.
    Speroff L. Postmenopausal hormone therapy and breast cancer. Obstet Gynecol 1996;87:44S-54S.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Janet P. Realini

There are no affiliations available

Personalised recommendations